Alright, here it comes! 
Oscar Health is an American health insurance company that combines both insurance and technology. It offers clear, easy-to-use health plans for individuals, families, and small businesses. In addition, the company’s own digital services, such as remote doctor appointments and wellness-tracking applications, simplify daily healthcare and “reward” healthy lifestyles. According to the company, their goal is to make insurance understandable and smooth.
More from an investor’s perspective:
Oscar has grown strongly in terms of membership and revenue. The company’s advantages include expansion through successful acquisitions and its proprietary technology platform, which opens new revenue streams and strengthens its competitive position in a somewhat old-fashioned industry.
The company’s challenges include achieving profitability, a strict regulatory environment, and laws that can lead to unexpected additional costs or challenging business model changes. Competition in the industry is fierce, forcing continuous innovation.
The outlook shows growth potential, especially in digital services, and on the other hand, certain legislative changes may also benefit Oscar. Success partly depends on whether Oscar Health can leverage its strengths, such as its technology, and manage various cost and regulatory risks. The markets in which Oscar operates are also highly competitive.
Ideally, it goes something like this: the company successfully continues to modernize health insurance operations with its mobile platform, making joining, claims, and managing related matters easier, which will increasingly be reflected in future growth and profitability. At the same time, growth and profitability are being improved by AI-powered infrastructures that increasingly succeed in lightening the cost burden while creating an even better customer experience, which then leads to stronger membership growth and increased partnerships.
A somewhat old-fashioned industry needs innovation.
Not a fact, but my own gut feeling is that Oscar Health would be a relatively “traded” (treifattu) stock. 
Reading material
From this, one can see that Oscar Health is relatively small, still has a high valuation, but also a low debt level and a better net margin than its competitors.
https://x.com/TrendSpider/status/1954520607653089452
Let’s add this one here too
https://x.com/TheTechInvest/status/1954492255257145755
10.8.2025
| Current | 3/31/2025 | 12/31/2024 | 9/30/2024 | 6/30/2024 | 3/31/2024 | |
|---|---|---|---|---|---|---|
| Market Cap | 3.99B | 3.32B | 3.37B | 5.24B | 3.75B | 3.42B |
| EDIT: EV removed, was incorrect | ||||||
| Forward P/E | – | 18.45 | 19.53 | – | – | – |
| Price/Sales | 0.36 | 0.38 | 0.46 | 0.77 | 0.58 | 0.56 |
| Price/Book | 3.44 | 3.28 | 2.90 | 4.61 | 3.70 | 4.37 |
| EV/Revenue | 0.16 | 0.23 | 0.30 | 0.45 | 0.28 | 0.31 |
(Investing.com, Yahoo, Google)
). I then had to remove them completely, as I couldn’t get them right anymore.
and I added subtitles because it’s sometimes hard to understand speech, especially in English. 
